{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:45:41Z","timestamp":1790779541564,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000010","name":"Ford Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"HHMI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","bmn.com","clinicalkey.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tins.2024.06.006","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:06:42Z","timestamp":1721826402000},"page":"583-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Do metabolic deficits contribute to sleep disruption in monogenic intellectual disability syndromes?"],"prefix":"10.1016","volume":"47","author":[{"given":"Mariela Lopez","family":"Valencia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folasade A.","family":"Sofela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Jongens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2024.06.006_bb0005","series-title":"Intellectual disability: definition, diagnosis, classification, and systems of supports","author":"Tass\u00e9","year":"2021"},{"key":"10.1016\/j.tins.2024.06.006_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-genet-110410-132512","article-title":"Genetic and epigenetic networks in intellectual disabilities","volume":"45","author":"van Bokhoven","year":"2011","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/archdischild-2013-304063","article-title":"Genetics and the investigation of developmental delay\/intellectual disability","volume":"99","author":"Srour","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.tins.2024.06.006_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.smrv.2011.03.006","article-title":"Sleep disturbances in children with multiple disabilities","volume":"16","author":"Tietze","year":"2012","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.tins.2024.06.006_bb0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.sleep.2010.01.010","article-title":"Sleep in children with autistic spectrum disorder","volume":"11","author":"Cortesi","year":"2010","journal-title":"Sleep Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5409\/wjcp.v11.i3.239","article-title":"Management of sleep disorders among children and adolescents with neurodevelopmental disorders: a practical guide for clinicians","volume":"11","author":"Ogundele","year":"2022","journal-title":"World J. Clin. Pediatr."},{"key":"10.1016\/j.tins.2024.06.006_bb0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fpsyt.2019.00366","article-title":"Systematic review of sleep disturbances and circadian sleep desynchronization in autism spectrum disorder: toward an integrative model of a self-reinforcing loop","volume":"10","author":"Carmassi","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.tins.2024.06.006_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/pch\/17.2.84","article-title":"Behaviour disorders in children with an intellectual disability","volume":"17","author":"Ageranioti-B\u00e9langer","year":"2012","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.tins.2024.06.006_bb0045","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1469-7610.2009.02110.x","article-title":"Sleep problems, sleepiness and daytime behavior in preschool-age children","volume":"50","author":"Goodlin-Jones","year":"2009","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.tins.2024.06.006_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s11689-018-9226-0","article-title":"A cross-syndrome cohort comparison of sleep disturbance in children with Smith\u2013Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex","volume":"10","author":"Trickett","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.tins.2024.06.006_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/metabo13030447","article-title":"Metabolomic studies in inborn errors of metabolism: last years and future perspectives","volume":"13","author":"Cossu","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.tins.2024.06.006_bb0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.21435","article-title":"Yield of additional metabolic studies in neurodevelopmental disorders","volume":"64","author":"Engbers","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2024.06.006_bb0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/pch\/19.9.469","article-title":"Early identification of treatable inborn errors of metabolism in children with intellectual disability: the Treatable Intellectual Disability Endeavor protocol in British Columbia","volume":"19","author":"van Karnebeek","year":"2014","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.tins.2024.06.006_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.a.30226","article-title":"Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation","volume":"133A","author":"Ara\u00fajo","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tins.2024.06.006_bb0075","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/01.wnl.0000239153.39710.81","article-title":"High frequency of creatine deficiency syndromes in patients with unexplained mental retardation","volume":"67","author":"Lion-Fran\u00e7ois","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2024.06.006_bb0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.tins.2024.06.006_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-981-15-2389-2_9","article-title":"Animal model contributions to congenital metabolic disease","volume":"1236","author":"Moro","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tins.2024.06.006_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fneur.2014.00133","article-title":"Sleep and sleep disorders in rare hereditary diseases: a reminder for the pediatrician, pediatric and adult neurologist, general practitioner, and sleep specialist","volume":"5","author":"Gadoth","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2024.06.006_bb0095","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2007.09.006","article-title":"High-fat diet disrupts behavioral and molecular circadian rhythms in mice","volume":"6","author":"Kohsaka","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2024.06.006_bb0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature09253","article-title":"Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes","volume":"466","author":"Marcheva","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tins.2024.06.006_bb0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cub.2013.01.048","article-title":"Circadian disruption leads to insulin resistance and obesity","volume":"23","author":"Shi","year":"2013","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tins.2024.06.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101595","article-title":"Synaptic dysfunction connects autism spectrum disorder and sleep disturbances: a perspective from studies in model organisms","volume":"62","author":"Doldur-Balli","year":"2022","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.tins.2024.06.006_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00125817-200109000-00006","article-title":"FMR1 and the fragile X syndrome: human genome epidemiology review","volume":"3","author":"Crawford","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0120","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.tins.2024.06.006_bb0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/sleep\/33.5.679","article-title":"Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey","volume":"33","author":"Kronk","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.tins.2024.06.006_bb0130","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1542\/peds.2013-4301","article-title":"Fragile X syndrome: a review of associated medical problems","volume":"134","author":"Kidd","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.tins.2024.06.006_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/1096-8628(20001211)95:4<307::AID-AJMG3>3.0.CO;2-3","article-title":"Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study","volume":"95","author":"Gould","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0140","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.clinph.2008.03.004","article-title":"Sleep phenotypes of intellectual disability: a polysomnographic evaluation in subjects with Down syndrome and fragile-X syndrome","volume":"119","author":"Miano","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.tins.2024.06.006_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/neuro.04.022.2009","article-title":"Fragile X mental retardation 1 and filamin a interact genetically in Drosophila long-term memory","volume":"3","author":"Bolduc","year":"2010","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.tins.2024.06.006_bb0150","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0896-6273(02)00724-9","article-title":"Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest","volume":"34","author":"Dockendorff","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.06.006_bb0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","article-title":"Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome","volume":"45","author":"McBride","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.06.006_bb0160","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1523\/JNEUROSCI.4830-08.2009","article-title":"The Drosophila fragile X mental retardation gene regulates sleep need","volume":"29","author":"Bushey","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.06.006_bb0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2108\/zsj.25.561","article-title":"Circadian phenotypes of Drosophila fragile X mutants in alternative genetic backgrounds","volume":"25","author":"Sekine","year":"2008","journal-title":"Zool. Sci."},{"key":"10.1016\/j.tins.2024.06.006_bb0170","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0960-9822(02)01036-9","article-title":"A role for the Drosophila fragile X-related gene in circadian output","volume":"12","author":"Inoue","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tins.2024.06.006_bb0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbr.2005.11.004","article-title":"Social behavior deficits in the Fmr1 mutant mouse","volume":"168","author":"Mineur","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0180","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1600-079X.2008.00653.x","article-title":"Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome","volume":"46","author":"Romero-Zerbo","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0185","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/hmg\/ddl121","article-title":"Exaggerated behavioral phenotypes in Fmr1\/Fxr2 double knockout mice reveal a functional genetic interaction between fragile X-related proteins","volume":"15","author":"Spencer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fnmol.2017.00280","article-title":"Deficient sleep in mouse models of fragile X syndrome","volume":"10","author":"Sar\u00e9","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tins.2024.06.006_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajhg.2008.06.003","article-title":"Fragile X-related proteins regulate mammalian circadian behavioral rhythms","volume":"83","author":"Zhang","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0896-6273(93)90324-K","article-title":"The neurofibromatosis type 1 gene and its protein product, neurofibromin","volume":"10","author":"Gutmann","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.06.006_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0888-7543(95)80104-T","article-title":"Genomic organization of the neurofibromatosis 1 gene (NF1)","volume":"25","author":"Li","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.tins.2024.06.006_bb0210","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.tins.2024.06.006_bb0215","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/ajmg.a.35915","article-title":"Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adults","volume":"161A","author":"Leschziner","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tins.2024.06.006_bb0220","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/0883073813500849","article-title":"Prevalence of sleep disturbances in children with neurofibromatosis type 1","volume":"28","author":"Licis","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.tins.2024.06.006_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-8749.2005.tb01128.x","article-title":"Psychological disturbance and sleep disorders in children with neurofibromatosis type 1","volume":"47","author":"Johnson","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.tins.2024.06.006_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.795951","article-title":"Early developmental trajectories in infants with neurofibromatosis 1","volume":"13","author":"Garg","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.tins.2024.06.006_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-024-03078-0","article-title":"Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1","volume":"19","author":"Cieza Rivera","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.tins.2024.06.006_bb0240","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1126\/science.276.5313.791","article-title":"Rescue of a Drosophila NF1 mutant phenotype by protein kinase A","volume":"276","author":"The","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.tins.2024.06.006_bb0245","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1534\/g3.115.026484","article-title":"Neurofibromin loss of function drives excessive grooming in Drosophila","volume":"6","author":"King","year":"2016","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.tins.2024.06.006_bb0250","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/35002593","article-title":"A neurofibromatosis-1-regulated pathway is required for learning in Drosophila","volume":"403","author":"Guo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tins.2024.06.006_bb0255","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1523\/JNEUROSCI.0933-07.2007","article-title":"Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation","volume":"27","author":"Ho","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.06.006_bb0260","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1126\/science.1063097","article-title":"A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras\/MAPK","volume":"293","author":"Williams","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tins.2024.06.006_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005611","article-title":"Anaplastic lymphoma kinase acts in the Drosophila mushroom body to negatively regulate sleep","volume":"11","author":"Bai","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ng0397-281","article-title":"A mouse model for the learning and memory deficits associated with neurofibromatosis type I","volume":"15","author":"Silva","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0280","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","article-title":"Immortalization of human normal and NF1 neurofibroma Schwann cells","volume":"96","author":"Li","year":"2016","journal-title":"Lab. Investig."},{"key":"10.1016\/j.tins.2024.06.006_bb0285","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12816","article-title":"Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentation","volume":"28","author":"Anastasaki","year":"2019","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2016.07.001","article-title":"Mosaic disorders of the PI3K\/PTEN\/AKT\/TSC\/mTORC1 signaling pathway","volume":"35","author":"Nathan","year":"2017","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.tins.2024.06.006_bb0295","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways","volume":"14","author":"Kwiatkowski","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yebeh.2010.10.023","article-title":"Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review","volume":"20","author":"van Eeghen","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.tins.2024.06.006_bb0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2788.1993.tb00868.x","article-title":"Development, behaviour and seizures in 300 cases of tuberous sclerosis","volume":"37","author":"Hunt","year":"1993","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0310","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0387-7604(94)00118-H","article-title":"Sleep disorders in tuberous sclerosis: a polysomnographic study","volume":"17","author":"Bruni","year":"1995","journal-title":"Brain and Development"},{"key":"10.1016\/j.tins.2024.06.006_bb0315","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cub.2010.05.027","article-title":"AKT and TOR signaling set the pace of the circadian pacemaker","volume":"20","author":"Zheng","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tins.2024.06.006_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171848","article-title":"TOR signaling pathway and autophagy are involved in the regulation of circadian rhythms in behavior and plasticity of L2 interneurons in the brain of Drosophila melanogaster","volume":"12","author":"Kijak","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2024.06.006_bb0325","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1038\/nature11310","article-title":"Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice","volume":"488","author":"Tsai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tins.2024.06.006_bb0330","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.06.006_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104615","article-title":"Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex","volume":"134","author":"Zhang","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2024.06.006_bb0340","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.celrep.2017.07.008","article-title":"Aberrant proteostasis of BMAL1 underlies circadian abnormalities in a paradigmatic mTOR-opathy","volume":"20","author":"Lipton","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2024.06.006_bb0345","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2007.06.074","article-title":"A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice","volume":"1168","author":"Ogawa","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0350","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1093\/hmg\/ddu057","article-title":"Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests","volume":"23","author":"Clipperton-Allen","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.1320600317","article-title":"Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county","volume":"60","author":"Petersen","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0360","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/ajmg.a.36058","article-title":"Angelman syndrome in Denmark. Birth incidence, genetic findings, and age at diagnosis","volume":"161","author":"Mertz","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tins.2024.06.006_bb0365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jmg.40.2.87","article-title":"Angelman syndrome: a review of the clinical and genetic aspects","volume":"40","author":"Clayton-Smith","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0370","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2010.01.026","article-title":"The Angelman syndrome-associated ubiquitin ligase Ube3A regulates synapse development by ubiquitinating Arc","volume":"140","author":"Greer","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tins.2024.06.006_bb0375","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajmg.a.36864","article-title":"Angelman syndrome in adulthood","volume":"167A","author":"Larson","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tins.2024.06.006_bb0380","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.sleep.2007.07.001","article-title":"Are there distinctive sleep problems in Angelman syndrome?","volume":"9","author":"Pelc","year":"2008","journal-title":"Sleep Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0385","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13023-024-03154-5","article-title":"Sleep disturbance in Angelman syndrome patients","volume":"19","author":"Qu","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.tins.2024.06.006_bb0390","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.sleep.2012.06.015","article-title":"Melatonin profile and its relation to circadian rhythm sleep disorders in Angelman syndrome patients","volume":"13","author":"Takaesu","year":"2012","journal-title":"Sleep Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0395","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.sleep.2003.06.004","article-title":"Identification and treatment of obstructive sleep apnea in adults and children with epilepsy: a prospective pilot study","volume":"4","author":"Malow","year":"2003","journal-title":"Sleep Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0400","article-title":"Drosophila UBE3A regulates satiety signaling through the Piezo mechanosensitive ion channel","author":"Geier","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.tins.2024.06.006_bb0405","doi-asserted-by":"crossref","first-page":"12399","DOI":"10.1073\/pnas.0805291105","article-title":"A Drosophila model for Angelman syndrome","volume":"105","author":"Wu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2024.06.006_bb0410","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","article-title":"Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation","volume":"21","author":"Jiang","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.06.006_bb0415","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2012.12.052","article-title":"Behavioral deficits in an Angelman syndrome model: effects of genetic background and age","volume":"243","author":"Huang","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0420","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.1523\/JNEUROSCI.2194-15.2015","article-title":"Maternal Ube3a loss disrupts sleep homeostasis but leaves circadian rhythmicity largely intact","volume":"35","author":"Ehlen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.06.006_bb0425","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cub.2014.12.047","article-title":"Ube3a imprinting impairs circadian robustness in Angelman syndrome models","volume":"25","author":"Shi","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tins.2024.06.006_bb0430","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/oby.23368","article-title":"Height and BMI in fragile X syndrome: a longitudinal assessment","volume":"30","author":"Choo","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.tins.2024.06.006_bb0435","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1399-0004.1987.tb03155.x","article-title":"A peculiar subphenotype in the fra(X) syndrome: extreme obesity\u2013short stature\u2013stubby hands and feet\u2013diffuse hyperpigmentation. Further evidence of disturbed hypothalamic function in the fra(X) syndrome?","volume":"32","author":"Fryns","year":"1987","journal-title":"Clin. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0440","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/138920211795677886","article-title":"Fragile X syndrome","volume":"12","author":"McLennan","year":"2011","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.tins.2024.06.006_bb0445","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.DBP.0000267563.18952.c9","article-title":"The Prader\u2013Willi phenotype of fragile X syndrome","volume":"28","author":"Nowicki","year":"2007","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.tins.2024.06.006_bb0450","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5582\/irdr.2016.01082","article-title":"The neurobiology of the Prader\u2013Willi phenotype of fragile X syndrome","volume":"5","author":"Muzar","year":"2016","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0455","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ajmg.a.36850","article-title":"Cholesterol levels in fragile X syndrome","volume":"167","author":"Berry-Kravis","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tins.2024.06.006_bb0460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/hmg\/ddx387","article-title":"Loss of Drosophila FMRP leads to alterations in energy metabolism and mitochondrial function","volume":"27","author":"Weisz","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0465","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/mp.2016.51","article-title":"Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model","volume":"22","author":"Monyak","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2024.06.006_bb0470","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/ddu737","article-title":"The fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice","volume":"24","author":"Lumaban","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0475","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/1346-8138.13218","article-title":"Nutritional, muscular and metabolic characteristics in patients with neurofibromatosis type 1","volume":"43","author":"Koga","year":"2016","journal-title":"J. Dermatol."},{"key":"10.1016\/j.tins.2024.06.006_bb0480","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clnesp.2019.05.006","article-title":"Increased resting metabolism in neurofibromatosis type 1","volume":"32","author":"de Souza","year":"2019","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.tins.2024.06.006_bb0485","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/hmg\/ddt515","article-title":"NF1 is a critical regulator of muscle development and metabolism","volume":"23","author":"Sullivan","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0490","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/ddx423","article-title":"Dietary intervention rescues myopathy associated with neurofibromatosis type 1","volume":"27","author":"Summers","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.20945\/2359-3997000000007","article-title":"Increased insulin sensitivity in individuals with neurofibromatosis type 1","volume":"62","author":"Martins","year":"2018","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.tins.2024.06.006_bb0500","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.trsl.2020.08.001","article-title":"Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1","volume":"228","author":"Tritz","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0505","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng2004","article-title":"Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster","volume":"39","author":"Tong","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0510","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1038\/s41467-021-24505-x","article-title":"Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila","volume":"12","author":"Botero","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2024.06.006_bb0515","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.celrep.2018.03.014","article-title":"A conserved circadian function for the neurofibromatosis 1 gene","volume":"22","author":"Bai","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2024.06.006_bb0520","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.tins.2024.06.006_bb0525","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa1113966","article-title":"PTEN mutations as a cause of constitutive insulin sensitivity and obesity","volume":"367","author":"Pal","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40348-022-00135-1","article-title":"PTEN hamartoma tumor syndrome in childhood and adolescence \u2013 a comprehensive review and presentation of the German pediatric guideline","volume":"9","author":"Plamper","year":"2022","journal-title":"Mol. Cell. Pediatr."},{"key":"10.1016\/j.tins.2024.06.006_bb0535","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/hmg\/ddy118","article-title":"Metabolomic studies identify changes in transmethylation and polyamine metabolism in a brain-specific mouse model of tuberous sclerosis complex","volume":"27","author":"McKenna","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0540","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ajmg.a.36923","article-title":"Are Angelman and Prader\u2013Willi syndromes more similar than we thought? Food-related behavior problems in Angelman, Cornelia de Lange, fragile X, Prader\u2013Willi and 1p36 deletion syndromes","volume":"167","author":"Welham","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tins.2024.06.006_bb0545","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.a.61382","article-title":"An overview of health issues and development in a large clinical cohort of children with Angelman syndrome","volume":"182","author":"Bindels-de Heus","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.tins.2024.06.006_bb0550","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.ridd.2014.07.025","article-title":"Eating behavior, prenatal and postnatal growth in Angelman syndrome","volume":"35","author":"Mertz","year":"2014","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.tins.2024.06.006_bb0555","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0560","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2024.06.006_bb0565","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nm.4335","article-title":"Metformin ameliorates core deficits in a mouse model of fragile X syndrome","volume":"23","author":"Gantois","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0570","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cge.13039","article-title":"Metformin as targeted treatment in fragile X syndrome","volume":"93","author":"Dy","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.tins.2024.06.006_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.956","article-title":"Metformin treatment in young children with fragile X syndrome","volume":"7","author":"Biag","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0580","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.psyneuen.2014.07.002","article-title":"Dietary supplementation of omega-3 fatty acids rescues fragile X phenotypes in Fmr1-Ko mice","volume":"49","author":"Pietropaolo","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tins.2024.06.006_bb0585","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2006.05.007","article-title":"Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2024.06.006_bb0590","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/ijms18061314","article-title":"Melatonin as a novel interventional candidate for fragile X syndrome with autism spectrum disorder in humans","volume":"18","author":"Won","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tins.2024.06.006_bb0595","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fnbeh.2019.00141","article-title":"Gaboxadol normalizes behavioral abnormalities in a mouse model of fragile X syndrome","volume":"13","author":"Cogram","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.tins.2024.06.006_bb0600","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002130100819","article-title":"The GABAA agonist gaboxadol improves the quality of post-nap sleep","volume":"157","author":"Mathias","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tins.2024.06.006_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237097","article-title":"Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1)","volume":"15","author":"Vasiljevski","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2024.06.006_bb0610","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86336","article-title":"Modulation of sleep by trafficking of lipids through the Drosophila blood\u2013brain barrier","volume":"12","author":"Li","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.tins.2024.06.006_bb0615","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41593-023-01568-1","article-title":"A neuron\u2013glia lipid metabolic cycle couples daily sleep to mitochondrial homeostasis","volume":"27","author":"Haynes","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2024.06.006_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001824","article-title":"Lowered insulin signalling ameliorates age-related sleep fragmentation in Drosophila","volume":"12","author":"Metaxakis","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tins.2024.06.006_bb0625","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tins.2024.06.006_bb0630","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cmet.2008.09.006","article-title":"Regulation of feeding and metabolism by neuronal and peripheral clocks in Drosophila","volume":"8","author":"Xu","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2024.06.006_bb0635","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/phar.1920","article-title":"Effectiveness of sleep-based interventions for children with autism spectrum disorder: a meta-synthesis","volume":"37","author":"Cuomo","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tins.2024.06.006_bb0640","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2788.2007.01016.x","article-title":"Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study","volume":"52","author":"Braam","year":"2008","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.tins.2024.06.006_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113949","article-title":"Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism","volume":"156","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tins.2024.06.006_bb0650","first-page":"553","article-title":"Sleep deprivation: impact on cognitive performance","volume":"3","author":"Alhola","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.tins.2024.06.006_bb0655","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archpedi.162.4.336","article-title":"Sleep problems in children with attention-deficit\/hyperactivity disorder: prevalence and the effect on the child and family","volume":"162","author":"Sung","year":"2008","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.tins.2024.06.006_bb0660","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10545-018-0146-7","article-title":"The functional genomics laboratory: functional validation of genetic variants","volume":"41","author":"Rodenburg","year":"2018","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223624001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223624001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T16:13:52Z","timestamp":1723565632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223624001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0166223624001206"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2024.06.006","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do metabolic deficits contribute to sleep disruption in monogenic intellectual disability syndromes?","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2024.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}